Bronchopulmonary Dysplasia (BPD) - Nov. 21, 2024
Severe chronic lung disease (CLD) of infancy, also known as bronchopulmonary dysplasia (BPD), is the most common chronic complication of premature birth. It affects approximately 25% of preterm infants with birth weights less than 1,500 grams and more than 50% of infants weighing less than 750 grams. Infants with BPD frequently require lengthy hospital stays and costly post-discharge medical care. A diagnosis of BPD is a strong predictor of long-term impairment in lung function, cardiovascular health, growth and neurodevelopment. Management of infants with severe CLD/BPD presents a unique challenge due to its multisystem involvement and common association with multiple non-lung comorbidities. A coordinated, evidence-based, multidisciplinary approach is crucial to achieve the best outcomes for this high-risk population.
Through specific lectures and discussion led by experts in the field of BPD, this conference will enhance participant’s fund of knowledge and teach practical management strategies to improve the care of infants with evolving and established severe BPD. This program will be of interest for anyone who will care for, or interact with, babies with severe BPD during their birth hospitalization.
Target Audience
This multidisciplinary course is intended for physicians, advanced practice nurses, physician assistants, nurses, respiratory therapists and other members of the healthcare team such as occupational therapists, physical therapists, speech-language pathologists, dietitians and social workers who provide care for patients with CLD/ BPD and their families.
Learning Objectives
- Describe how practical communication tools and team structure can improve the family experience.
- Review local family engagement efforts for families of babies with severe BPD.
- Explain management strategies to reduce ventilator dyssynchrony.
- Describe interventions that can be utilized in babies with hyperinflation.
- Discuss options for state regulation in infants with severe BPD and the benefits and risks of each agent
Additional Information
Attachment | Size |
---|---|
Participant Parking Guide BPD.pdf | 20.61 MB |
AGENDA | November 21, 2024 | |
8:30 AM | 9:00 AM | Registration, Breakfast and Attendance Check-In |
9:00 AM | 9:10 AM | Welcome and Opening Remarks Sadie Houin, MD Krugman Conference Hall Research Complex RC2 |
9:10 AM | 9:50 AM | Ventilator Dyssynchrony in babies with severe BPD Katie Gibbs, MD |
9:50 AM | 10:00 AM | Break |
10:00 AM | 10:30 AM | Bedside RT assessment and trouble shooting: Panelists Respiratory Therapists |
10:30 AM | 11:15 AM | Hyperinflation Laurie Eldridge, MD PhD |
11:15 AM | 11:45 AM | Engagement at the Bedside Panelists RN, PT, SW |
11:45 AM | 12:45 PM | Lunch - Provided Live Learners |
12:45 PM | 1:30 PM | Hope is an unfinished story: using communication tools and teams to support families of babies with severe BPD Laurie Sherlock, MD Kathleen Hannan, MD MSCS |
1:30 PM | 2:30 PM | Parent/Family experience Parent Panelists of SPROUT Babies |
2:30 PM | 2:45 PM | Break |
2:45 PM | 3:15 PM | Pharmacology in grade 3 BPD Emma Ross, PharmD |
3:15 PM | 3:30 PM | Closing remarks Evaluation and Adjourn |
Conflict of Interest Disclosure of Relevant Financial Relationships for Planners, Faculty, Content Experts and Content Reviewers
As a provider of continuing medical education (CME) by the Accreditation Council for Continuing Medical Education (ACCME) and nursing continuing professional development (NCPD) by Colorado Nurses Association, Children's Hospital Colorado ensures balance, independence, objectivity and scientific rigor in all its CME/NCPD activities.
To comply with ACCME and NCPD accreditation guidelines, each planner, faculty, content expert and content reviewer(s) in a position to control content of this educational activity are required to disclose all relevant financial relationships with ineligible companies in the last 24 months.
Disclosure: Planners, faculty, and others in control of content (either individually or as a group) have no relevant financial relationships with ineligible companies. Full Faculty Disclosure will be provided prior to the course.
Conference Faculty
Satya Houin, MD
Assistant Professor of Pediatrics, University of Colorado, Section of Neonatology
Attending Neonatologist
Director of Supporting Preemie Respiratory OUTcome (SPROUT) team for BPD
Children’s Hospital Colorado
Kathleen Hannan, MD MSCS
Assistant Professor of Pediatrics, University of Colorado, Section of Neonatology
SPROUT team, Director of Research and Innovation
Laurie Sherlock, MD
Assistant Professor of Pediatrics, University of Colorado, Section of Neonatology
Attending Neonatologist
SPROUT team
STORK team Co-Director
Erica Mandell, MD MPH
Associate Professor of Pediatrics, University of Colorado, Section of Neonatology
Attending Neonatologist
SPROUT team
Kathleen Gibbs, MD
Medical Director, Newborn and Infant Chronic Lung Disease Program
Medical Director, Quality Improvement and Patient Safety (N/IICU)
Attending Neonatologist
Professor of Clinical Pediatrics
Laurie Eldredge, MD, PhD
Codirector, Seattle Children’s Bronchopulmonary Dysplasia Team PI,
Seattle Children’s Center for Respiratory Biology and Therapeutics
Assistant Professor
University of Washington School of Medicine, Dept of Pediatrics,
Division of Pulmonary and Sleep Medicine
Emma L. Ross, PharmD, BCPPS,
Neonatal Clinical Pharmacy Specialist
Amy Peck MSN, RNC-NIC
Gretchen O'Brien, BSN RNC-NIC
Greta Leinbach, BSN, RNC-NIC
Brittney Stribny, PT
Doctor of PT
Certified Neonatal Therapist
Neonatal Touch and Massage Therapist
Beth McManus, PT
Relevant financial relationship - Financial relationships are relevant if the following three conditions are met for the prospective person who will control content of the education.
A financial relationship, in any amount, exists between the person in control of content and an ineligible company.
The financial relationship existed during the past 24 months.
Content of the education is related to the products of an ineligible company with whom the person has a financial relationship.
Ineligible company - is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Medical
Children’s Hospital Colorado is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Children’s Hospital Colorado designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Others
A general certificate of attendance will be available after the completion of the online evaluation.
Available Credit
- 5.00 AMA PRA Category 1 Credit™
- 5.00 Attendance
- 5.00 Approved AMA PRA Category 1 Credit™